Published in J Virol on May 01, 1983
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24
Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol (2011) 1.98
How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol (2010) 1.23
Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg (1958) 40.44
The serum proteins in multiple myelomatosis. Biochem J (1940) 23.49
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Production of Plaques in Monolayer Tissue Cultures by Single Particles of an Animal Virus. Proc Natl Acad Sci U S A (1952) 19.83
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med (1977) 7.01
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90
Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin. J Exp Med (1974) 3.39
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
A simple micro-culture method for the study of group B arboviruses. Bull World Health Organ (1969) 2.75
Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse. J Immunol (1966) 2.68
Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61
Growth characteristics of monkey kidney cell strains LLC-MK1, LLC-MK2, and LLC-MK2(NCTC-3196) and their utility in virus research. J Exp Med (1962) 2.59
Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med (1970) 2.13
Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07
ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS. Aust J Exp Biol Med Sci (1964) 1.68
Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature (1979) 1.65
THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES. Virology (1963) 1.59
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale J Biol Med (1970) 1.45
A multi-hit model for the neutralization of animal viruses. J Gen Virol (1978) 1.41
Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. J Immunol (1981) 1.33
Pathogenesis of feline infectious peritonitis: nature and development of viremia. Am J Vet Res (1981) 1.30
Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro. J Immunol Methods (1978) 1.28
The enchancement of virus infectivity by antibody. Virology (1967) 1.19
Acute rabies death mediated by antibody. Nature (1981) 1.17
EA rosette forming lymphoid cells: distribution as to cell types and organs from chickens of different developmental stages. Cell Immunol (1976) 1.05
In vitro assay of mitogen stimulation of avian peripheral lymphocytes. Avian Dis (1975) 1.01
Influence of host cell on residual infectivity of neutralized vesicular stomatitis virus. Virology (1959) 0.96
An explanation for enhanced virus plaque formation in chick embryo cells. Nature (1980) 0.95
Particle counts and some chemical properties of Murray Valley encephalitis virus. J Gen Microbiol (1962) 0.84
Ontogeny of spontaneous antigen-binding cells in developing chick embryos. Immunology (1979) 0.83
Studies on the non-neutralizable fraction of vaccinia virus. Clin Exp Immunol (1970) 0.83
Antibody-mediated enhancement of rabies virus. Nature (1981) 0.82
The development of bactericidal activity in rat peritoneal macrophages. Aust J Exp Biol Med Sci (1968) 0.81
The establishment of continuous macrophage cell lines from peripheal blood monocytes. Immunology (1980) 0.80
Studies on the mechanism of antibody-mediated enhancement of Getah virus infectivity. Biken J (1981) 0.79
EA rosette-forming lymphoid cells in chickens: specificity of the Fc receptor and its relationship to other surface antigens. Immunology (1976) 0.77
Is there an inapparent dengue explosion? Lancet (1999) 7.28
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med (1977) 7.01
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol (1984) 5.62
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med (1970) 4.41
Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg (1969) 4.41
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97
In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90
Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med (1970) 3.88
Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol (2000) 3.70
Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet (1996) 3.30
Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol (1967) 3.22
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Original antigenic sin in dengue. Am J Trop Med Hyg (1983) 2.82
A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg (1999) 2.78
Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg (1969) 2.62
Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis (1973) 2.48
Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr (1966) 2.45
Dengue haemorrhagic fever--a public health problem and a field for research. Bull World Health Organ (1980) 2.39
Mosquito-borne haemorrhagic fevers of South and South-East Asia. Bull World Health Organ (1966) 2.39
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol (1985) 2.31
Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med (1970) 2.13
Dengue d chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. Am J Trop Med Hyg (1969) 2.11
Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg (1969) 2.07
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Immune enhancement of viral infection. Prog Allergy (1982) 1.94
The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am J Epidemiol (1981) 1.85
Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. Rev Infect Dis (1984) 1.66
Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg (1980) 1.65
Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J Infect Dis (1994) 1.64
Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings. Proc Soc Exp Biol Med (1976) 1.60
Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis (1973) 1.55
Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol (1984) 1.54
Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg (1974) 1.49
Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys. J Infect Dis (1976) 1.49
Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. Yale J Biol Med (1970) 1.48
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale J Biol Med (1970) 1.45
Dengue and chikungunya virus infection in man in Thailand, 1962-1964. V. Epidemiologic observations outside Bangkok. Am J Trop Med Hyg (1969) 1.44
Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis (1973) 1.42
Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol (1990) 1.40
Dengue carrier culture and antigen production in human lymphoblastoid lines. Intervirology (1975) 1.37
Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet (2000) 1.32
Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro. J Immunol Methods (1978) 1.28
A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody. Arch Virol (1975) 1.27
Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of agspecific sequential infection rates using a mathematical model. Yale J Biol Med (1970) 1.23
Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic? J Trop Med Hyg (1977) 1.19
Booster vaccination with further live attenuated measles vaccine. JAMA (1976) 1.18
Transmission of dengue 1 and 2 viruses in Greece in 1928. Am J Trop Med Hyg (1980) 1.17
Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet (2001) 1.16
Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. J Gen Virol (1987) 1.15
Serological response to rubella revaccination. JAMA (1984) 1.15
Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series. JAMA (1978) 1.15
Recent virological studies on haemorrhagic fever and other arthropod-borne virus infections in the Philippines. J Trop Med Hyg (1966) 1.14
Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg (1991) 1.13
Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg (1973) 1.12
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg (1984) 1.11
Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis (1997) 1.11
Profiles of antibody-dependent enhancement of dengue virus type 2 infection. Microb Pathog (1987) 1.10
Inhibition of dengue virus replication by amantadine hydrochloride. Antimicrob Agents Chemother (1980) 1.10
Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids. Cytobios (1987) 1.09
Dengue hemorrhagic fever in South Vietnam: report of the 1963 outbreak. Am J Trop Med Hyg (1965) 1.07
Dengue and hemorrhagic fevers of Southeast Asia. Yale J Biol Med (1965) 1.06
Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res Hum Retroviruses (1994) 1.05
Human antibody to dengue soluble complement-fixing (SCF) antigens. J Immunol (1973) 1.05
Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses (1993) 1.05
Studies of bladder stone disease in Thailand. II. Hospital experience. Urolithiasis at Ubol Provincial Hospital, 1956-1962. Am J Clin Nutr (1967) 1.04
Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies. Am J Trop Med Hyg (1984) 1.04
Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies. Am J Trop Med Hyg (1983) 0.99
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels. Am J Trop Med Hyg (1984) 0.96
Rubella antibody persistence after immunization. JAMA (1982) 0.96
An explanation for enhanced virus plaque formation in chick embryo cells. Nature (1980) 0.95
Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and children. Infect Immun (1979) 0.92
Rubella in an immunized island population. JAMA (1973) 0.91
Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules. J Infect Dis (1998) 0.91
Rubella vaccination: fertility control in a large-scale vaccination program for postpubertal women. Am J Obstet Gynecol (1975) 0.91
Phytohemagglutinin enhancement of dengue-2 virus replication in nonimmune rhesus monkey peripheral blood leukocytes. Infect Immun (1978) 0.89
Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies. J Med Virol (1987) 0.89
Dengue: hematologic aspects. Semin Hematol (1982) 0.89
Immunopathogenesis of dengue infection in the rhesus monkey. Transplant Proc (1974) 0.89
Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies. J Med Virol (1987) 0.89
Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin. Antimicrob Agents Chemother (1983) 0.88
Vertebrate hosts of chikungunya virus. Bull World Health Organ (1966) 0.87
Rubella immunization. Persistence of antibody four years after a large-scale field trial. JAMA (1976) 0.87
Nonspecific factors in monkey tissues and serum causing inhibition of plaque formation and hemagglutination by dengue viruses. Infect Immun (1971) 0.87
Japanese encephalitis: update on vaccines and vaccine recommendations. Curr Opin Infect Dis (2010) 0.87
Studies of bladder stone disease in Thailand. VI. Urinary studies in children, 2-10 years old, resident in a hypo- and hyperendemic area. Am J Clin Nutr (1967) 0.87
In vitro virulence marker: growth of dengue-2 virus in human leukocyte suspension cultures. Infect Immun (1981) 0.86
Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro. Antiviral Res (1982) 0.86
Editorial response: Resuscitation of patients with dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis (1999) 0.85
Comparison of dengue virus plaque reduction neutralization by macro and "semi-micro' methods in LLC-MK2 cells. Microbiol Immunol (1985) 0.85
Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses. Am J Trop Med Hyg (1973) 0.84
Studies of bladder stone disease in Thailand. IV. Dietary habits, nutritional intake, and infant feeding practices among residents of a hypo- and hyperendemic area. Am J Clin Nutr (1967) 0.83
Susceptibility of rubella among adolescents and adults in Hawaii. JAMA (1969) 0.83
Clinical and laboratory studies on haemorrhagic fever in Burma, 1970-72. Bull World Health Organ (1974) 0.83
Suppression of dengue virus replication in vitro by rimantadine hydrochloride. Am J Trop Med Hyg (1981) 0.83
Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians. Am J Trop Med Hyg (1988) 0.82
Incidence of infectious mononucleosis at the Universities of California and Hawaii. J Infect Dis (1979) 0.82